# OnCo record anvumetostat (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/anvumetostat/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "anvumetostat" ;
  schema:name "Anvumetostat"@en ;
  schema:alternateName "MTA Cooperative PRMT5 inhibitor"@en, "AMG 193"@en ;
  schema:description "Anvumetostat is an experimental small-molecule drug from Amgen in phase 2 trials for non-small-cell lung cancer, aimed at PRMT5 (MTAP-deleted cancers)."@en ;
  schema:url <https://onco.cc/drugs/anvumetostat/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Anvumetostat> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/prmt5-mtap/> ;
  onco:companies <https://onco.cc/companies/amgen/> ;
  onco:trials <https://onco.cc/trials/nct05094336/>, <https://onco.cc/trials/nct06593522/> .